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Infracarpal Upper Extremity Arterial Bypass: Is it Worth it?
Philip S K Paty, Benjamin B Chang, R Clement Darling, III, Sean P Roddy,
Manish Mehta, Paul B Kreienberg, Kathleen J Ozsvath, Yaron Sternbach,
John B Taggert, Dhiraj M Shah. Albany Medical College, Albany, NY
Objectives: Patients presenting with digital ischemia and arterial
occlusion distal to the wrist are a disadvantaged population with renal
failure, collagen vascular disease and hypercoaguable states and difficult
technical options for revascularization. A nonaggressive stance to treat-
ment in these patients often leads to significant digit/hand loss and thus
we have approached these patients aggressively in order to try to improve
limb salvage.
Methods: A retrospective review of all upper extremity bypasses per-
formed to arteries distal to the wrist was performed. All patients were
evaluated with biplanar arteriography. Patients with hypercoaguable states
and rheumatoid arthitides/collagen vascular disease (RA) were medically
evaluated prior to operation. Postoperative surveillance was performed with
PVR and Duplex scan. Vein bypasses were performed in all cases. Patency
was computed according to life table methods.
Results: Between 1993 and 2008, 40 bypasses were performed in 34
patients for digital gangrene (20), rest pain (13) and ulcer (5). There were 19
males and 15 females. Patient risk factors included diabetes (17), active smoking
(17), hypertension (13), hyperlipidemia (8), Coronary disease (10) and renal
failure (18). Documented hypercoaguable states and RA were present in four
and 12 patients, respectively. Outflow arteries included distal radial (29), distal
ulnar (1), palmar arch (7) and common digital arteries (3). Venous conduit
included saphenous and cephalic veins in reversed (34), nonreversed (3) and
spliced (3) configuration. There was no operativemortality. Digital amputation
was performed in 19patients for gangrene andminor debridement in 4 patients.
There were 5 bypass occlusions all of which occurred in the first year. Cumula-
tive patency from this point on was 84% (mean follow up: 22 months (range:
1-184 months)). Cumulative survival was 57% at 2 years and 26% at 5 years.
Conclusions: Arterial bypass in patients with infracarpal upper extrem-
ity arterial disease is challenging but may be achieved with excellent patency.
Digital amputation is often required. Long term survival in these patients is
limited and perioperative management of patient risk factors important.
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Natural History of Mesenteric Artery Stent Restenoses and Clinical
and Anatomic Predictors for Re-intervention in Patients with Chronic
Mesenteric Ischemia
Gustavo S. Oderich, Thanila A. Macedo, Rafael Malgor, Joseph J. Ricotta,
II, Terri Vrtiska, Audra A. Duncan, Manju Kalra, Peter Gloviczki. Mayo
Clinic, Rochester, MN
Objectives: To determine the natural history, clinical and anatomical
predictors of mesenteric artery stent (MAS) restenosis in patients with
chronic mesenteric ischemia (CMI).
Methods: The clinical data of 102 patients treated with 127 MAS for
CMI was entered into a prospective database (2001-2006). Data was
reviewed in 87 patients (57 female, 30 male; median age 77 years) with
imaging follow up 3months (mean 2822 months). Pre-procedure com-
puted tomography angiography (CTA) with centerline of flow analysis and
biplanar angiography were reviewed to determine anatomic measurements.
Mesenteric restenosis was defined as60% restenosis by CTA, angiography
or duplex ultrasound. Univariate and logistic regression analysis was per-
formed to identify factors associated with restenosis.
Results: There were 71 SMA and 35 celiac stents. Forty-seven patients
(54%) developed restenosis. Symptomatic restenoses in 17 patients (13 chronic,
4 acute) were treated with re-intervention (12 endovascular, 3 open) in all
except 2 patients who died of unrelated causes. Asymptomatic restenoses in 30
patients (23 with angiographic confirmation) were followed for 3025
months: 4 (13%) developed symptoms (3 chronic, 1 acute) and 8 had re-
interventions (4 prophylactic). There were no deaths associated with re-inter-
ventions and82patients (94%) referred symptom improvement at their last visit.
Freedom from restenosis, recurrence and re-intervention at 3-years was 356%,
657% and 657%. Primary and secondary patency rates were 607% and
865% at same intervals. There were more (P.05) restenoses in female
patients (63% vs 37%), and those with occlusions (100% vs 46%), severe
calcification (80% vs 40%), longer lesions (30mm, 71% vs 52%) and vessel
diameter 7mm (63% vs 21%). Occlusions and severe calcification were inde-
pendently associated with higher risk of restenosis (P.01).
Conclusion: MAS restenoses occur in approximately half of the pa-
tients, of which half develop recurrent mesenteric ischemia. Our results
support a conservative approach for asymptomatic restenosis and a policy ofearly re-intervention in the presence of symptoms. Patients with longer or
calcified lesions and those with residual post-procedure stenosis have the
highest re-intervention rates.
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Visceral Artery Duplex Ultrasound Velocity Criteria for Instent Steno-
sis Following Mesenteric Artery Stenting: Validated with Arteriogra-
phy
Christopher L Stout1, Cory A Messerschmidt2, Greg C Schmieder1, Albert
I Richardson, II1, Gordon K Stokes1, Jean M Panneton1. 1Division of
Vascular Surgery, Eastern Virginia Medical School, Norfolk, VA; 2Eastern
Virginia Medical School, Norfolk, VA
Objectivs: The number of patients undergoing endovascular therapy for
mesenteric ischemia is rapidly increasing. The accuracy of mesenteric duplex
ultrasound (DUS) has not been established for the prediction of in-stent
restenosis (ISR) of the celiac (CA) or superior mesenteric artery (SMA). The
purpose of this study is to determineDUS velocity criteria formesenteric stents.
Methods: A retrospective review all consecutive patients that under-
went endovascular stenting from July 2004 to July 2008 was completed.
The angiography (DSA) and DUS were performed within three months of
each other to be considered paired measurements. Standard statistical anal-
ysis was performed.
Results: There were 53 SMA and 17 CA ultrasound and angiography
pairs. CA analysis of receiver operator curves (ROC) showed no discrimina-
tion betweenDUS and greater than 70% stenosis onDSA, p0.65. Using all
CA paired studies, a velocity of 226 cm/s has a sensitivity of 1 and specificity
of 0.33 and a velocity of 449 cm/s has a sensitivity of 0.50 and specificity of
0.87 (Table 1). SMA analysis of ROC curves showed an AUC of 0.74
between DUS and greater than 70% stenosis on DSA, p0.007. Using all
paired SMA studies, a velocity of 302 cm/s has a sensitivity of 1 and
specificity of 0.5 and a velocity of 645 cm/s has a sensitivity of 0.27 and
specificity of 1 (Table 1).
Conclusions: Duplex ultrasound grading of stent restenosis for mes-
enteric vessels has not been validated. Superior mesenteric artery stent
stenosis can be diagnosed with good sensitivity and PPV using DUS. This
data can help guide the decision to perform arteriography for specific DUS
velocities of mesenteric stents.
Table 1. Celiac Artery ROC Analysis
DUS (cm/s) Sensitivity Specificity PPV NPV
226 1 0.33 0.17 1.00
263 0.50 0.40 0.10 0.86
337 0.50 0.47 0.11 0.88
350 0.50 0.53 0.13 0.90
365 0.50 0.67 0.17 0.91
425 0.50 0.73 0.20 0.92
449 0.50 0.87 0.33 0.93
460 0.50 0.93 0.50 0.93
Table 2. Superior mesenteric artery ROC analysis
DUS (cm/s) Sensitivity Specificity PPV NPV
302 1 0.48 0.23 1
320 1 0.50 0.23 1
335 0.86 0.50 0.21 0.96
343 0.86 0.52 0.21 0.96
362 0.71 0.52 0.19 0.92
375 0.71 0.57 0.20 0.93
403 0.57 0.65 0.20 0.91
417 0.43 0.67 0.17 0.89
462 0.43 0.76 0.21 0.90
482 0.43 0.80 0.25 0.90
506 0.43 0.85 0.30 0.91
525 0.43 0.87 0.33 0.91
549 0.43 0.91 0.43 0.91
609 0.27 0.98 0.67 0.90
645 0.27 1 1 0.90
